Cardiovascular risk in Chinese patients with chronic kidney diseases: where do we stand?

被引：0
|
作者：
Hou, FF [1 ]
机构：
[1] Nanfang Med Univ, Nanfang Hosp, Div Nephrol, Guangzhou 510515, Peoples R China
来源：
CHINESE MEDICAL JOURNAL | 2005年 / 118卷 / 11期
关键词：
cardiovascular disease; chronic kidney disease; epidemiology;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：883 / 886
页数：4
相关论文
共 50 条
  • [1] Alcohol and cardiovascular diseases: where do we stand today?
    Klatsky, A. L.
    JOURNAL OF INTERNAL MEDICINE, 2015, 278 (03) : 238 - 250
  • [2] Phosphate binders in moderate chronic kidney disease: where do we stand?
    Bellasi, Antonio
    Cozzolino, Mario
    Adragao, Teresa
    Di Iorio, Biagio
    Russo, Domenico
    JOURNAL OF NEPHROLOGY, 2013, 26 (06) : 993 - 1000
  • [3] Breast arterial calcification for personalized cardiovascular risk assessment: Where do we stand?
    Cainzos-Achirica, Miguel
    Tota-Maharaj, Rajesh
    ATHEROSCLEROSIS, 2017, 259 : 101 - 103
  • [4] Lipoprotein(a) and Atherosclerotic Cardiovascular Disease: Where Do We Stand?
    Tsioulos, Georgios
    Kounatidis, Dimitris
    Vallianou, Natalia G.
    Poulaki, Aikaterini
    Kotsi, Evangelia
    Christodoulatos, Gerasimos Socrates
    Tsilingiris, Dimitrios
    Karampela, Irene
    Skourtis, Alexandros
    Dalamaga, Maria
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (06)
  • [5] Obesity paradox in cardiovascular disease: where do we stand?
    Carbone, Salvatore
    Canada, Justin M.
    Billingsley, Hayley E.
    Siddiqui, Mohammad S.
    Elagizi, Andrew
    Lavie, Carl J.
    VASCULAR HEALTH AND RISK MANAGEMENT, 2019, 15 : 89 - 100
  • [6] The role of vitamin D deficiency in cardiovascular disease: where do we stand in 2013?
    Pilz, Stefan
    Gaksch, Martin
    O'Hartaigh, Briain
    Tomaschitz, Andreas
    Maerz, Winfried
    ARCHIVES OF TOXICOLOGY, 2013, 87 (12) : 2083 - 2103
  • [7] Xenotransplantation of pancreatic and kidney primordia-Where do we stand?
    Hammerman, Marc R.
    TRANSPLANT IMMUNOLOGY, 2009, 21 (02) : 93 - 100
  • [8] Obstructive Sleep Apnea and Cardiovascular Disease: Where Do We Stand?
    Peker, Yuksel
    Akdeniz, Bahri
    Altay, Servet
    Balcan, Baran
    Basaran, Ozcan
    Baysal, Erkan
    Celik, Ahmet
    Dursunoglu, Dursun
    Dursunoglu, Nese
    Firat, Selma
    Gurkan, Canan Gunduz
    Ozturk, Onder
    Tasbakan, Mehmet Sezai
    Aytekin, Vedat
    Itil, Oya
    Cuhadaroglu, Caglar
    Atalar, Enver
    Yildirir, Aylin
    ANATOLIAN JOURNAL OF CARDIOLOGY, 2023, 27 (07) : 375 - 389
  • [9] Frailty, sarcopenia and diabetic kidney disease: where do we stand?
    Karakousis, Nikolaos D.
    Biliou, Smaragda
    Pyrgioti, Elisavet E.
    Georgakopoulos, Petros N.
    Liakopoulos, Vassilios
    Papanas, Nikolaos
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2023, 55 (05) : 1173 - 1181
  • [10] Do patients with chronic kidney disease get optimal cardiovascular risk reduction?
    Elliott, Mark K.
    McCaughan, Jennifer A.
    Fogarty, Damian G.
    CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 2014, 23 (03) : 267 - 274
12345